Document Detail


Early airway pressure release ventilation prevents ARDS-a novel preventive approach to lung injury.
MedLine Citation:
PMID:  23247119     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Acute respiratory distress syndrome (ARDS) afflicts 200,000 patients annually with a mortality rate of 30% to 60% despite wide use of low tidal volume (LTV) ventilation, the present standard of care. High-permeability alveolar edema and instability occur early in the development of ARDS, before clinical signs of lung injury, and represent potential targets for therapy. We hypothesize that early application of a protective ventilation strategy (airway pressure release ventilation [APRV]) will stabilize alveoli and reduce alveolar edema, preventing the development of ARDS. Yorkshire pigs (30-40 kg) were anesthetized and subjected to two-hit injury: (a) intestinal ischemia-reperfusion, (b) peritoneal sepsis, or sham surgery. Following surgery, pigs were randomized into APRV (n = 4), according to current published guidelines for APRV; LTV ventilation (n = 3), using the current published ARDS Network guidelines (6 mL/kg); or sham (n = 5). The clinical care of all pigs was administered per the Surviving Sepsis Campaign guidelines. Animals were killed, and necropsy performed at 48 h. Arterial blood gases were measured to assess for the development of clinical lung injury. Lung tissue epithelial cadherin (E-cadherin) was measured to assess alveolar permeability. Bronchoalveolar lavage fluid (BALF) surfactant protein A was measured to assess alveolar stability. Lung edema content and histopathology were analyzed at 48 h. Airway pressure release ventilation pigs did not develop ARDS. In contrast, pigs in the LTV ventilation met ARDS criteria (PaO2/FIO2 ratio) (APRV: baseline = 471 ± 16; 48 h = 392 ± 8; vs. LTV ventilation: baseline = 551 ± 28; 48 h = 138 ± 88; P < 0.001). Airway pressure release ventilation preserved alveolar epithelial integrity demonstrated by higher levels of E-cadherin in lung tissue as compared with LTV ventilation (P < 0.05). Surfactant protein A levels were higher in BALF from the APRV group, suggesting APRV preserved alveolar stability. Quantitative histologic scoring showed improvements in all stigmata of ARDS in the APRV group versus the LTV ventilation (P < 0.05). Airway pressure release ventilation had significantly lower lung edema (wet-dry weight) than LTV ventilation (P < 0.05). Protective ventilation with APRV immediately following injury prevents development of ARDS. Reduction in lung edema, preservation of lung E-cadherin, and surfactant protein A abundance in BALF suggest that APRV attenuates lung permeability, edema, and surfactant degradation. Protective ventilation could change the clinical paradigm from supportive care for ARDS with LTV ventilation to preventing development of ARDS with APRV.
Authors:
Shreyas Roy; Nader Habashi; Benjamin Sadowitz; Penny Andrews; Lin Ge; Guirong Wang; Preyas Roy; Auyon Ghosh; Michael Kuhn; Joshua Satalin; Louis A Gatto; Xin Lin; David A Dean; Yoram Vodovotz; Gary Nieman
Related Documents :
23161359 - Predictive value of pulse pressure variation for fluid responsiveness in septic patient...
3958189 - Adaptation during surgical stress. a reevaluation of the role of glucocorticoids.
23329819 - Separating in vivo mechanical stimuli for postpneumonectomy compensation: imaging and u...
19145779 - Cardiac and renal baroreflex control during stress in conscious renovascular hypertensi...
11020099 - Anger, harassment, and cardiovascular reactivity among chinese and indian men in singap...
10355479 - Aerobic exercise attenuates blood pressure reactivity to cold pressor test in normotens...
24583749 - The correlation between manometric and videofluoroscopic measurements of the swallowing...
23028839 - Modulation of invasive phenotype by interstitial pressure-driven convection in aggregat...
1849369 - Postexcitatory depression of baroreceptors in dogs with experimental heart failure.
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Shock (Augusta, Ga.)     Volume:  39     ISSN:  1540-0514     ISO Abbreviation:  Shock     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2012-12-18     Completed Date:  2013-06-03     Revised Date:  2014-01-10    
Medline Journal Info:
Nlm Unique ID:  9421564     Medline TA:  Shock     Country:  United States    
Other Details:
Languages:  eng     Pagination:  28-38     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Lung Injury / pathology,  physiopathology,  prevention & control*
Animals
Bronchoalveolar Lavage Fluid / chemistry
Cadherins / metabolism
Carbon Dioxide / blood
Continuous Positive Airway Pressure / methods*
Female
Hemodynamics / physiology
Lung Compliance / physiology
Multiple Organ Failure / prevention & control
Oxygen / blood
Partial Pressure
Pulmonary Edema / prevention & control
Pulmonary Surfactant-Associated Protein A / metabolism
Respiratory Distress Syndrome, Adult / pathology,  physiopathology,  prevention & control*
Severity of Illness Index
Sus scrofa
Tidal Volume / physiology
Time Factors
Water-Electrolyte Balance / physiology
Grant Support
ID/Acronym/Agency:
R21 HL092801/HL/NHLBI NIH HHS; R21HL092801-01/HL/NHLBI NIH HHS; R33 HL089076/HL/NHLBI NIH HHS; R33HL089076/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Cadherins; 0/Pulmonary Surfactant-Associated Protein A; 142M471B3J/Carbon Dioxide; S88TT14065/Oxygen
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Silencing of fas, fas-associated via death domain, or caspase 3 differentially affects lung inflamma...
Next Document:  Parasympathetic stimulation via the vagus nerve prevents systemic organ dysfunction by abrogating gu...